BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30801340)

  • 1. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.
    Aung PP; Nagarajan P; Tetzlaff MT; Curry JL; Tang G; Abdullaev Z; Pack SD; Ivan D; Prieto VG; Torres-Cabala CA
    Am J Dermatopathol; 2019 Mar; 41(3):167-179. PubMed ID: 30801340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z; Buljan M; Busam KJ
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
    Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
    Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
    Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
    J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations.
    Mochel MC; Piris A; Nose V; Hoang MP
    Am J Clin Pathol; 2015 Jun; 143(6):901-4. PubMed ID: 25972334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes.
    Busam KJ; Sung J; Wiesner T; von Deimling A; Jungbluth A
    Am J Surg Pathol; 2013 Feb; 37(2):193-9. PubMed ID: 23026932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation.
    Gerami P; Yélamos O; Lee CY; Obregon R; Yazdan P; Sholl LM; Guitart GE; Njauw CN; Tsao H
    JAMA Dermatol; 2015 Nov; 151(11):1235-9. PubMed ID: 26154183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome.
    Busam KJ; Wanna M; Wiesner T
    JAMA Dermatol; 2013 Mar; 149(3):335-9. PubMed ID: 23552620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
    Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC
    Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: A pilot study.
    Cabaret O; Perron E; Bressac-de Paillerets B; Soufir N; de la Fouchardière A
    Genes Chromosomes Cancer; 2017 Sep; 56(9):691-694. PubMed ID: 28560743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel insights into the BAP1-inactivated melanocytic tumor.
    Donati M; Martinek P; Steiner P; Grossmann P; Vanecek T; Kastnerova L; Kolm I; Baneckova M; Donati P; Kletskaya I; Kalmykova A; Feit J; Blasch P; Szilagyi D; Baldi A; Persichetti P; Crescenzi A; Michal M; Kazakov DV
    Mod Pathol; 2022 May; 35(5):664-675. PubMed ID: 34857909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoexpression of BAP1, ROS1, and ALK in Spitzoid Melanocytic Tumors.
    Cardili L; Viana CR; Germano A; Fernandes M; Barcellos D; Landman G
    Int J Surg Pathol; 2018 Sep; 26(6):514-520. PubMed ID: 29623743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
    Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAP1-deficient and VE1-negative atypical Spitz tumor.
    Requena C; Sanz V; Nagore E; García-Casado Z; Rubio L; Guillén C; Kutzner H
    J Cutan Pathol; 2015 Aug; 42(8):564-7. PubMed ID: 25953246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome.
    Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N
    Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations in BAP1 predispose to melanocytic tumors.
    Wiesner T; Obenauf AC; Murali R; Fried I; Griewank KG; Ulz P; Windpassinger C; Wackernagel W; Loy S; Wolf I; Viale A; Lash AE; Pirun M; Socci ND; Rütten A; Palmedo G; Abramson D; Offit K; Ott A; Becker JC; Cerroni L; Kutzner H; Bastian BC; Speicher MR
    Nat Genet; 2011 Aug; 43(10):1018-21. PubMed ID: 21874003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature.
    Wysozan TR; Khelifa S; Turchan K; Alomari AK
    J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature.
    Donati M; Šteiner P; Kazakov DV
    Am J Dermatopathol; 2023 Feb; 45(2):117-122. PubMed ID: 36669076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.